Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
122
天
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
作者
Wenqian Zhang; Ying Yu; Falk Hertwig; Jean Thierry-Mieg; Wenwei Zhang; Danielle Thierry-Mieg; Jian Wang; Cesare Furlanello; Viswanath Devanarayan; Jie Cheng; Youping Deng; Barbara Hero; Huixiao Hong; Meiwen Jia; Li Li; Simon M Lin; Yuri Nikolsky; André Oberthuer; Tao Qing; Zhenqiang Su; Ruth Volland; Charles Wang; May D. Wang; Junmei Ai; Davide Albanese; Shahab Asgharzadeh; Smadar Avigad; Wenjun Bao; Marina Bessarabova; Murray H. Brilliant; Benedikt Brors; Marco Chierici; Tzu-Ming Chu; Jibin Zhang; Richard G. Grundy; Min Max He; Scott Hebbring; Howard L. Kaufman; Samir Lababidi; Lee J. Lancashire; Yan Li; Xin X. Lu; Heng Luo; Xiwen Ma; Baitang Ning; Rosa Noguera; Martin Peifer; John H. Phan; Frederik Roels; Carolina Rosswog; Susan Shao; Jie Shen; Jessica Theissen; Gian Paolo Tonini; Jo Vandesompele; Po-Yen Wu; Wenzhong Xiao; Joshua Xu; Weihong Xu; Jiekun Xuan; Yong Yang; Zhan Ye; Zirui Dong; Ke K. Zhang; Ye Yin; Chen Zhao; Yuanting Zheng; Russell D. Wolfinger; Tieliu Shi; Linda H. Malkas; Frank Berthold; Jun Wang; Weida Tong; Leming Shi; Zhiyu Peng; Matthias Fischer展开收起
作者单位
1. BGI-Shenzhen, Main Building, Bei Shan Industrial Zone, Shenzhen, China; 2. Collaborative Innovation Center for Genetics and Development, State Key Laboratory of Genetic Engineering and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences and School of Pharmacy, Fudan University, Shanghai, China; 3. Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Cologne, Germany; 4. University of Cologne, Center for Molecular Medicine (CMMC), Medical Faculty, Cologne, Germany; 5. NIH/NCBI, Bethesda, USA; 6. Eli Lilly and Company Research Informatics, Lilly Corporate Center, Indianapolis, USA; 7. Fondazione Bruno Kessler (FBK), Trento Povo, Italy; 8. AbbVie Inc., Global Pharmaceutical R&D, Souderton, USA; 9. GlaxoSmithKline, Discovery Analytics, Collegeville, USA; 10. Department of Internal Medicine, Rush University Cancer Center, Chicago, USA; 11. National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, USA; 12. SAS Institute Inc., Cary, USA; 13. Marshfield Clinic Research Foundation, Biomedical Informatics Research Center, Marshfield, USA; 14. Thomson Reuters IP & Science, Carlsbad, USA; 15. Center for Genomics and Division of Microbiology & Molecular Genetics, School of Medicine, Loma Linda University, Loma Linda, USA; 16. Department of Biomedical Engineering, GeorgiaTech and Emory University, Atlanta, USA; 17. Fondazione Edmund Mach, CRI-CBC, San Michele all’Adige, Italy; 18. Children’s Hospital Los Angeles, Los Angeles, USA; 19. Department of Pediatric Hematology-Oncology, Molecular Oncology, Felsenstein Medical Research Center, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel; 20. Marshfield Clinic Research Foundation, Center of Human Genetics, Marshfield, USA; 21. Department of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany; 22. University of Nottingham, Children’s Brain Tumour Research Centre, Queen’s Medical Centre, University of Nottingham, Nottingham, UK; 23. Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, WOC1 RM400S, HFM-210, Rockville, USA; 24. AbbVie Inc., Global Pharmaceutical Research and Development, North Chicago, USA; 25. University of Arkansas at Little Rock, UALR/UAMS Joint Bioinformatics Graduate Program, Little Rock, USA; 26. Eli Lilly and Company, Discovery Statistics, Lilly Corporate Center, Indianapolis, USA; 27. Department of Pathology, University of Valencia, Medical School, Valencia, Spain; 28. Department of Translational Genomics, University of Cologne, Cologne, Germany; 29. Neuroblastoma Laboratory, Onco/Hematology Laboratory, SDB Department, University of Padua, Pediatric Research Institute, Padua, Italy; 30. Department of Pediatrics and Genetics, Ghent University, Center for Medical Genetics, Ghent University, Ghent, Belgium; 31. Georgia Institute of Technology, School of Electrical and Computer Engineering, Atlanta, USA; 32. Harvard Medical School, Massachusetts General Hospital, Boston, USA; 33. Stanford University, Stanford Genome Technology Center, Palo Alto, USA; 34. Department of Pathology, University of North Dakota School of Medicine, Grand Forks, USA; 35. East China Normal University, Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory of Regulatory Biology, the Institute of Biomedical Sciences and School of Life Sciences, Shanghai, China; 36. Department of Molecular & Cellular Biology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, USA; 37. Department of Biology, University of Copenhagen, Copenhagen, Denmark; 38. King Abdulaziz University, Jeddah, Saudi Arabia; 39. Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark; 40. BGI-Guangzhou, Guangzhou Higher Education Mega Center, Guangzhou, China展开收起
46
天
FOXM1 binds directly to non-consensus sequences in the human genome
作者
Deborah A. Sanders; Michael V. Gormally; Giovanni Marsico; Dario Beraldi; David Tannahill; Shankar Balasubramanian展开收起
作者单位
1. Cancer Research UK, Cambridge Research Institute, Cambridge, UK; 2. Present address: Domainex, Cambridge, UK; 3. Department of Chemistry, University of Cambridge, Cambridge, UK; 4. School of Clinical Medicine, The University of Cambridge, Cambridge, UK展开收起
91
天
Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells
作者
Kyu-Tae Kim; Hye Won Lee; Hae-Ock Lee; Sang Cheol Kim; Yun Jee Seo; Woosung Chung; Hye Hyeon Eum; Do-Hyun Nam; Junhyong Kim; Kyeung Min Joo; Woong-Yang Park展开收起
作者单位
1. Samsung Genome Institute, Samsung Medical Center, Seoul, South Korea; 2. Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, South Korea; 3. Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, South Korea; 4. Department of Urology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea; 5. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea; 6. Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Seoul, South Korea; 7. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea; 8. Department of Biology, University of Pennsylvania, Philadelphia, USA; 9. Penn Program in Single Cell Biology, University of Pennsylvania, Philadelphia, USA; 10. Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Seoul, South Korea展开收起
128
天
Extensive rewiring of epithelial-stromal co-expression networks in breast cancer
作者
Eun-Yeong Oh; Stephen M Christensen; Sindhu Ghanta; Jong Cheol Jeong; Octavian Bucur; Benjamin Glass; Laleh Montaser-Kouhsari; Nicholas W Knoblauch; Nicholas Bertos; Sadiq MI Saleh; Benjamin Haibe-Kains; Morag Park; Andrew H Beck展开收起
作者单位
1. Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, USA; 2. Department of Pathology, Beth Israel Deaconess Medical Center, Boston, USA; 3. Harvard Medical School, Boston, USA; 4. Goodman Cancer Research Centre, McGill University, Montreal, Canada; 5. Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; 6. Department of Medical Biophysics, University of Toronto, Toronto, Canada展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天